RT Journal Article
SR Electronic
T1 Efficacy and safety of anti-PD1 monotherapy or in combination with ipilimumab after BRAF/MEK inhibitors in patients with BRAF mutant metastatic melanoma
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e004610
DO 10.1136/jitc-2022-004610
VO 10
IS 7
A1 Pires da Silva, Ines
A1 Zakria, Danny
A1 Ahmed, Tasnia
A1 Trojanello, Claudia
A1 Dimitriou, Florentia
A1 Allayous, Clara
A1 Gerard, Camille
A1 Zimmer, Lisa
A1 Lo, Serigne
A1 Michielin, Olivier
A1 Lebbe, Celeste
A1 Mangana, Johanna
A1 Ascierto, Paolo Antonio
A1 Johnson, Douglas B
A1 Carlino, Matteo
A1 Menzies, Alexander
A1 Long, Georgina
YR 2022
UL http://jitc.bmj.com/content/10/7/e004610.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.